At Outpost, we are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS). Located in Indianapolis and London, Outpost is a private company launched in 2016 with a $61 million Series A venture capital financing from Frazier Healthcare Partners, Adams Street Partners, Novo Holdings A/S, Vivo Capital, and Takeda Ventures.
View Top Employees from Outpost Medicine| Website | http://www.outpostmedicine.com |
| Revenue | $1 million |
| Funding | $132.5 million |
| Employees | 6 (6 on RocketReach) |
| Founded | 2016 |
| Technologies |
HTML,
Nginx,
Microsoft Outlook
+4 more
(view full list)
|
| Industry | Pharmaceuticals, Biotechnology, Biopharma, Healthcare, Health Care, Science and Engineering, Medical, Pharmaceutical |
| Competitors | Ironwood Pharmaceuticals, Legacy Healthcare LLC, Ritter Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Outpost Medicine employee's phone or email?
Outpost Medicine Questions
The Outpost Medicine annual revenue was $1 million in 2023.
Gale Kennedy is the Vice President, Clinical Development of Outpost Medicine.
6 people are employed at Outpost Medicine.
Outpost Medicine is based in Indianapolis, Indiana.
The NAICS codes for Outpost Medicine are [3254, 325, 32].
The SIC codes for Outpost Medicine are [283, 28].
Top Outpost Medicine Employees
-
ViewGale Kennedy
Vice President, Clinical Development at Outpost Medicine
London, England, United Kingdom1 -
23
-
2
Related Companies
